Annual EBIT:
-$568.20M+$639.54M(+52.95%)Summary
- As of today, ONC annual earnings before interest & taxes is -$568.20 million, with the most recent change of +$639.54 million (+52.95%) on December 31, 2024.
- During the last 3 years, ONC annual EBIT has risen by +$870.54 million (+60.51%).
- ONC annual EBIT is now -11889.85% below its all-time high of -$4.74 million, reached on December 1, 2013.
Performance
ONC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$87.89M+$76.78M(+691.61%)Summary
- As of today, ONC quarterly earnings before interest & taxes is $87.89 million, with the most recent change of +$76.78 million (+691.61%) on June 30, 2025.
- Over the past year, ONC quarterly EBIT has increased by +$195.05 million (+182.01%).
- ONC quarterly EBIT is now -23.52% below its all-time high of $114.91 million, reached on September 1, 2017.
Performance
ONC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$100.70M+$195.05M(+65.95%)Summary
- As of today, ONC TTM earnings before interest & taxes is -$100.70 million, with the most recent change of +$195.05 million (+65.95%) on June 30, 2025.
- Over the past year, ONC TTM EBIT has increased by +$785.57 million (+88.64%).
- ONC TTM EBIT is now -1113.14% below its all-time high of -$8.30 million, reached on September 1, 2014.
Performance
ONC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ONC EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +53.0% | +182.0% | +88.6% |
3Y3 Years | +60.5% | +120.0% | +94.8% |
5Y5 Years | +40.8% | +124.5% | +93.5% |
ONC EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +68.3% | at high | +118.8% | at high | +94.7% |
5Y | 5-Year | at high | +68.3% | at high | +115.4% | at high | +94.8% |
All-Time | All-Time | >-9999.0% | +68.3% | -23.5% | +115.4% | -1113.1% | +94.8% |
ONC EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $87.89M(+691.6%) | -$100.70M(+65.9%) |
Mar 2025 | - | $11.10M(+114.0%) | -$295.75M(+47.9%) |
Dec 2024 | -$568.20M(+53.0%) | -$79.42M(+34.0%) | -$568.20M(+34.9%) |
Sep 2024 | - | -$120.27M(-12.2%) | -$872.57M(+1.5%) |
Jun 2024 | - | -$107.16M(+59.0%) | -$886.27M(+19.3%) |
Mar 2024 | - | -$261.35M(+31.9%) | -$1.10B(+9.1%) |
Dec 2023 | -$1.21B(+32.5%) | -$383.80M(-186.5%) | -$1.21B(+6.6%) |
Sep 2023 | - | -$133.97M(+58.0%) | -$1.29B(+19.1%) |
Jun 2023 | - | -$318.71M(+14.2%) | -$1.60B(+7.0%) |
Mar 2023 | - | -$371.26M(+20.8%) | -$1.72B(+4.0%) |
Dec 2022 | -$1.79B(-24.4%) | - | - |
Dec 2022 | - | -$468.62M(-6.9%) | -$1.79B(+5.4%) |
Sep 2022 | - | -$438.36M(+0.2%) | -$1.89B(+1.3%) |
Jun 2022 | - | -$439.40M(+0.9%) | -$1.92B(+1.8%) |
Mar 2022 | - | -$443.29M(+22.5%) | -$1.95B(-35.7%) |
Dec 2021 | -$1.44B(+13.2%) | -$571.74M(-23.7%) | -$1.44B(-6.4%) |
Sep 2021 | - | -$462.32M(+2.6%) | -$1.35B(-1.7%) |
Jun 2021 | - | -$474.84M(-776.7%) | -$1.33B(-9.6%) |
Mar 2021 | - | $70.17M(+114.5%) | -$1.21B(+26.8%) |
Dec 2020 | -$1.66B(-72.7%) | -$484.91M(-10.2%) | -$1.66B(-6.2%) |
Sep 2020 | - | -$440.14M(-22.6%) | -$1.56B(-8.9%) |
Jun 2020 | - | -$358.88M(+4.0%) | -$1.43B(-23.5%) |
Mar 2020 | - | -$373.76M(+3.7%) | -$1.16B(-20.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | -$959.89M(-36.0%) | -$388.04M(-24.3%) | -$959.89M(-12.6%) |
Sep 2019 | - | -$312.27M(-263.8%) | -$852.66M(-23.3%) |
Jun 2019 | - | -$85.83M(+50.6%) | -$691.50M(+10.0%) |
Mar 2019 | - | -$173.75M(+38.1%) | -$768.72M(-8.9%) |
Dec 2018 | -$705.77M(-616.8%) | -$280.81M(-85.8%) | -$705.77M(-33.5%) |
Sep 2018 | - | -$151.10M(+7.3%) | -$528.76M(-101.2%) |
Jun 2018 | - | -$163.05M(-47.1%) | -$262.75M(-66.6%) |
Mar 2018 | - | -$110.81M(-6.8%) | -$157.72M(-60.2%) |
Dec 2017 | -$98.46M(+15.9%) | -$103.80M(-190.3%) | -$98.46M(-208.4%) |
Sep 2017 | - | $114.91M(+298.0%) | -$31.93M(+82.4%) |
Jun 2017 | - | -$58.02M(-12.6%) | -$181.66M(-22.5%) |
Mar 2017 | - | -$51.54M(-38.3%) | -$148.27M(-26.7%) |
Dec 2016 | -$117.06M(-106.3%) | -$37.27M(-7.0%) | -$117.06M(-8.9%) |
Sep 2016 | - | -$34.83M(-41.4%) | -$107.52M(-24.5%) |
Jun 2016 | - | -$24.63M(-21.1%) | -$86.39M(-28.7%) |
Mar 2016 | - | -$20.33M(+26.7%) | -$67.13M(-18.3%) |
Dec 2015 | -$56.74M(-260.1%) | -$27.73M(-102.4%) | -$56.74M(-70.9%) |
Sep 2015 | - | -$13.70M(-155.2%) | -$33.20M(-19.4%) |
Jun 2015 | - | -$5.37M(+46.0%) | -$27.80M(-23.9%) |
Mar 2015 | - | -$9.95M(-137.5%) | -$22.43M(-79.6%) |
Dec 2014 | -$15.76M(-232.5%) | -$4.19M(+49.5%) | -$12.49M(-50.5%) |
Sep 2014 | - | -$8.30M | -$8.30M |
Dec 2013 | -$4.74M | - | - |
FAQ
- What is BeOne Medicines Ltd. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual EBIT year-on-year change?
- What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?
- What is BeOne Medicines Ltd. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. TTM EBIT year-on-year change?
What is BeOne Medicines Ltd. annual earnings before interest & taxes?
The current annual EBIT of ONC is -$568.20M
What is the all-time high annual EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual earnings before interest & taxes is -$4.74M
What is BeOne Medicines Ltd. annual EBIT year-on-year change?
Over the past year, ONC annual earnings before interest & taxes has changed by +$639.54M (+52.95%)
What is BeOne Medicines Ltd. quarterly earnings before interest & taxes?
The current quarterly EBIT of ONC is $87.89M
What is the all-time high quarterly EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly earnings before interest & taxes is $114.91M
What is BeOne Medicines Ltd. quarterly EBIT year-on-year change?
Over the past year, ONC quarterly earnings before interest & taxes has changed by +$195.05M (+182.01%)
What is BeOne Medicines Ltd. TTM earnings before interest & taxes?
The current TTM EBIT of ONC is -$100.70M
What is the all-time high TTM EBIT for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high TTM earnings before interest & taxes is -$8.30M
What is BeOne Medicines Ltd. TTM EBIT year-on-year change?
Over the past year, ONC TTM earnings before interest & taxes has changed by +$785.57M (+88.64%)